How kidney immune cells respond to kidney injury
Response of kidney resident macrophages to proximal tubule injury
This study is looking at how certain immune cells in the kidneys help heal the organ after an injury, which is important for people who have had acute kidney injury, and it hopes to find new ways to treat this condition better.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-10917179 on NIH RePORTER |
What this research studies
This research investigates the role of kidney resident macrophages in response to acute kidney injury (AKI), a serious condition affecting many hospitalized patients. The study aims to understand the mechanisms by which these immune cells contribute to kidney healing and function restoration after injury. Using advanced techniques like single-cell RNA sequencing and spatial transcriptomics, researchers will identify different subpopulations of macrophages and their specific functions in the kidney environment. This research could lead to new therapeutic strategies for treating AKI, which currently lacks effective targeted treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients who have experienced acute kidney injury, particularly those hospitalized or critically ill.
Not a fit: Patients with chronic kidney disease or those who have not experienced acute kidney injury may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new therapies that improve recovery from acute kidney injury.
How similar studies have performed: Other research has shown promise in understanding immune responses in kidney injury, but this specific focus on kidney resident macrophages is relatively novel.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Cheung, Matthew David — University of Alabama at Birmingham
- Study coordinator: Cheung, Matthew David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.